Holdings
晟德大藥廠股份有限公司
As of Sep 30, 2026, 晟德大藥廠股份有限公司 reported 7 positions. Largest: Lumosa Therapeutics Co Ltd, Biogend Therapeutics Co., Ltd. and Medeon Biodesign, Inc. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| Lumosa Therapeutics Co Ltd | 57.9M | no change | Sep 30, 2026 | |
| Biogend Therapeutics Co., Ltd. | 45.2M | no change | Sep 30, 2026 | |
| Medeon Biodesign, Inc. | 23.5M | no change | Sep 30, 2026 | |
| Mycenax Biotech Inc. | 42.1M | no change | Sep 30, 2026 | |
| Anya Biopharm, Inc. | 8.27M | no change | Sep 30, 2026 | |
| Ever Supreme Bio Technology Co., Ltd. | 10.7M | −49,000 | Sep 30, 2026 | |
| Ever Fortune.ai Co., Ltd. | 3.52M | no change | Sep 30, 2026 | |
| Lumosa Therapeutics Co Ltd | no change | Oct 17, 2026 | ||
| Biogend Therapeutics Co., Ltd. | no change | Oct 17, 2026 | ||
| Mycenax Biotech Inc. | no change | Oct 17, 2026 |